The latest announcement is out from Soleno Therapeutics (SLNO).
Soleno Therapeutics, Inc. announced that Dr. Ernest Mario, Chairman of the Board, is resigning due to health reasons, with no disagreements over the company’s operations. Matthew Pauls and Andrew Sinclair have been appointed to key leadership roles in the Board, with Dawn C. Bir joining as a new director. Bir brings valuable pharmaceutical experience, having held significant positions at Reata Pharmaceuticals and other notable companies. Her appointment includes a grant of restricted stock units as part of the company’s compensation policy for non-employee directors. The company’s recent board changes were publicized through a press release.
See more insights into SLNO stock on TipRanks’ Stock Analysis page.
